1/ 🙏 patients, investigators and funders for
@TROGfightcancer 13.01 SAFRON II trial at #ESTRO21. n=90 pts with 133 pulmonary oligometastases, across 13 centers in 🇳🇿+🇦🇺. Median F/U = 3 years, randomization for single (SF) 28Gy vs 48Gy in 4fx (MF). #radonc #LCSM @PeterMacCC
2/ No difference in SF vs MF. Both were safe (G3+ AEs were 5% MF v 3% SF), and effective - 2yr OS 85% MF v 88% SF (p=0.44), LC 83% MF v 73% SF (p=0.13). No diff. in DFS (median 13.2 MF v 14.3 SF, p=0.99). Mean time to systemic treatment ~29mo. SABR did not impact QoL measures
3/ Both SF and MF arms drove systemic immune activation
- ⬆️%CD4+FoxP3+ Tregs, ⬆️ %CTLA-4 and %PD-1 expressing CD4+, CD8+ and/or CD4-CD8- T cell subsets
- modestly ⬆️ % change of CD4+ T cell and CD8+ T cell subsets expressing PD-1 or TIGIT in the SF arm as compared to MF arm
4/ Health Economics Analysis: TROG 13.01
- MF costs $1,121 AUD (30%) more than SF SABR.
- 2.43 QALYs in SF arm v 2.25 QALYs in MF arm.
- Major lifetime cost were post-progression therapies (i.e. systemic) at 5x initial costs; SF ($23,510) versus MF ($20,661) #lcsm #radonc
5/ TROG 13.01 SAFRON II is the first fully recruited randomized trial in patients with pulmonary oligometastases.
- SF picked as 'winner'
- outcomes comparable (? favorably) to surgery in PulMiCC study
- Equipoise for future RCT of SABR v surgery? #ESTRO2021 #LCSM #lungcancer
6/ Thank you @JAMAOnc for concurrently publishing the manuscript - found here, open access bit.ly/2Y8IOAb with editorial by @DrAryaAmin; in same edition - doi:10.1001/jamaoncol.2021.2926. 🙏🙏🙏 again for everyone's efforts, I'm very grateful!!!

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with Shankar Siva

Shankar Siva Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!